IRIS PubliCatt

Nero, Camilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 940
EU - Europa 770
AS - Asia 213
AF - Africa 12
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.944
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 933
IT - Italia 198
SE - Svezia 187
DE - Germania 132
CN - Cina 101
IE - Irlanda 72
SG - Singapore 49
UA - Ucraina 38
FR - Francia 32
GB - Regno Unito 27
RU - Federazione Russa 24
IN - India 21
FI - Finlandia 16
BE - Belgio 12
IR - Iran 8
KR - Corea 8
PH - Filippine 8
TR - Turchia 7
AT - Austria 6
CI - Costa d'Avorio 6
ES - Italia 6
CZ - Repubblica Ceca 5
NL - Olanda 5
CA - Canada 4
ID - Indonesia 4
BR - Brasile 3
GF - Guiana Francese 2
HR - Croazia 2
MA - Marocco 2
MD - Moldavia 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
PE - Perù 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
EG - Egitto 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.944
Salva come PNG Salva come JPEG
Città #
Chandler 263
Ashburn 111
Dublin 68
Rome 61
Ann Arbor 52
New York 35
Milan 34
San Mateo 34
Singapore 32
Boston 24
Wilmington 24
Jacksonville 23
Moscow 20
Princeton 19
Marseille 18
Nanjing 18
Beijing 15
Dearborn 15
Cattolica 13
Boardman 12
Nürnberg 11
Brussels 10
Fairfield 10
Lawrence 9
Leawood 9
Woodbridge 9
Washington 8
Bremen 7
Houston 7
Redwood City 7
Abidjan 6
Bari 6
Seattle 6
Vienna 6
Andover 5
Helsinki 5
Izmir 5
Mountain View 5
Augusta 4
Changsha 4
Hangzhou 4
London 4
Los Angeles 4
Madrid 4
Amsterdam 3
Detroit 3
Hebei 3
Hefei 3
Jeju City 3
Martellago 3
Nanchang 3
Norwalk 3
Olomouc 3
Redmond 3
Sanford 3
Sanremo 3
Shanghai 3
Toronto 3
Zhengzhou 3
Ardabil 2
Asti 2
Bollate 2
Brno 2
Cavite City 2
Cayenne 2
Chisinau 2
Civitavecchia 2
Clearwater 2
Coimbatore 2
Depok 2
Edinburgh 2
Frankfurt am Main 2
Gangnam-gu 2
Genazzano 2
Jinan 2
Katsina 2
Kuala Lumpur 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Leipzig 2
Lima 2
Manila 2
Mumbai 2
Munich 2
Osimo 2
Oujda 2
Pamplona 2
Paris 2
Parma 2
Pasay 2
Pineto 2
Rimini 2
Sala Consilina 2
Salò 2
San Francisco 2
San Giovanni 2
Seoul 2
Shaoxing 2
Shenzhen 2
Totale 1.173
Salva come PNG Salva come JPEG
Nome #
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 126
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 108
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 107
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine 97
Targeting the hallmarks of ovarian cancer: The big picture 78
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 72
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 69
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 67
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 64
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 64
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method 63
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 62
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 60
Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 55
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 53
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer 51
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 48
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 47
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer 45
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 44
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 44
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 44
Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma 42
Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY) 42
Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye 41
Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY) 37
Newly diagnosed ovarian cancer: Which first-line treatment? 36
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 34
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 32
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 29
Mesenteric Lymph Node Involvement in Advanced Ovarian Cancer Patients Undergoing Rectosigmoid Resection: Prognostic Role and Clinical Considerations 27
PARP Inhibitors Resistance: Mechanisms and Perspectives 25
Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy 23
Recent progress in the use of pharmacotherapy for endometrial cancer 22
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids 20
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 18
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 17
Advanced and recurrent endometrial cancer: State of the art and future perspectives 17
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 16
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma 16
Management of stage III and IVa uterine cancer 15
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 15
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 11
Radiomics and Radiogenomics of Ovarian Cancer: Implications for Treatment Monitoring and Clinical Management 8
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study 5
Totale 2.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.059
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020150 25 10 7 4 11 11 12 6 14 11 28 11
2020/2021126 12 8 6 8 16 8 8 5 12 10 26 7
2021/2022291 8 11 4 21 17 5 14 51 14 26 46 74
2022/2023706 87 93 49 113 32 88 34 48 73 16 29 44
2023/2024507 12 110 23 46 24 57 43 33 4 28 64 63
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 2.016